1. /
  2. Our work /
  3. Projects /
  4. Injecting drug use in Melbourne: SuperMIX cohort study
IMG 0964 510X288

Injecting drug use in Melbourne: SuperMIX cohort study

Open to students

SuperMIX is the largest and longest-running active cohort study of people who inject drugs in Australia, with over 1500 participants.

Since 2008, we have surveyed people who inject drugs in the Melbourne and the Greater Geelong region to:

  • understand rates of mortality, poor mental health, overdose, bloodborne virus (BBV) infections, injecting-related injuries and diseases (IRIDs), and chronic diseases such as chronic obstructive pulmonary disease (COPD) 
  • determine the effectiveness of existing and new health programs like drug treatment, take-home naloxone (THN) and supervised injecting facilities (SIFs). The goal is to improve health and help people stop usings drugs in the long-term 
  • evaluate the impacts of structural factors (like homelessness and imprisonment) on health outcomes.

A cohort study is a research method where scientists follow a group of people over time to see how certain things, like habits or exposures, affect their health.

 SuperMIX provides important information on how injecting drug use evolves over time. People in the study complete follow-up interviews once a year. They also consent to linking their past and future data to administrative health and social datasets. 

SuperMIX is part of a broader study called MIXMAX. This combines SuperMIX with VMAX—a study collecting data on methamphetamine use over time—to become the largest active cohort study of people who use drugs in Australia.

About the study

The SuperMIX study runs from a mobile van which visits different health services around Melbourne. Participants usually complete an interview in person with a researcher and have blood taken to test for blood borne viruses. Between 2020 and 2022, researchers switched to phone interviews due to the COVID-19 pandemic.

In August 2022:

  • 5,530 surveys were completed
  • 1,328 participants completed a baseline interview
  • 28 was the average age of participants at baseline interview
  • participants were involved in the study for 8.6 years on average
  • the average number of follow up surveys was 4.2.

Participant location

Participants are located all around Victoria. The following chart provides a breakdown of participant locations as at August 2022.

Accessible Pie Chart

The pie chart shows the percentage of study participants located in different areas of Victoria. Footscray has the highest percentage (38%), while Geelong has the lowest (1%). Other regions are represented as follows: North Richmond (19%), Frankston (16%), Central Business District (10%), Inner north (7%), St Kilda (6%), and Dandenong (5%).

Student opportunities

View 56 more

Social networks of people who use drugs

Help us understand the characteristics study participant social networks. Investigate the influence of these characteristics on drug-related risk behaviours and harms, including cessation from and relapse into drug use, and overdose. 

Tobacco/nicotine harm reduction among people with a history of illicit drug use

Quantitative research including: 

  • analysis of trends in prevalence of daily tobacco use, quantity of cigarettes smoked daily, and/or vape use 
  • analysis of longitudinal changes in individual smoking behaviours 
  • estimation of incidence of tobacco-related chronic disease hospital admissions. 

Measuring risk and health outcomes among women who use drugs

Qualitative and quantitative research, including: 

  • conducting in-depth interviews with study participants to better understand their experiences as people who inject drugs 
  • analysis of longitudinal survey data, characterising and assessing its suitability to understand behavioural risk and health outcomes among women. 
Open to
  • Honours
  • Masters by research
Vacancies

2

Understanding the needs of women who inject drugs

Qualitative and quantitative research, or mixed methods research including: 

  • conducting in-depth interviews with women of the SuperMIX study, to better understand their gendered experiences as people who inject drugs 
  • analysis of longitudinal SuperMIX survey data to characterise the qualitative research sample and/or understand and compare differences between selected variables (experiences) of men/women. 

Other publications

01 Jun 2023

Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.

The Lancet Gastroenterology and Hepatology

Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D

29 Jan 2023

Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: a pooled analysis of emulated trials.

Addiction

van Santen DK, Lodi S, Dietze P, van den Boom W, Hayashi K, Dong H, Cui Z, Maher L, Hickman M, Boyd A

23 Jan 2023

Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia.

Harm reduction journal

Schroeder SE, Wilkinson AL, O'Keefe D, Bourne A, Doyle JS, Hellard M, Dietze P, Pedrana A

14 Dec 2022

Trust and service engagement among people who inject drugs after release from prison.

The International journal on drug policy

Lafferty L, Schroeder S, Marshall AD, Drysdale K, Higgs P, Stoové M, Baldry E, Dietze P, Treloar C

24 Jun 2022

Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study.

Addiction (Abingdon, England)

Hill PL, Stoové M, Agius PA, Maher L, Hickman M, Crawford S, Dietze P

14 Jun 2022

Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX).

International journal of epidemiology

Van Den Boom W, Quiroga MDM, O'Keefe D, Kumar D, Hill PL, Scott N, Agius PA, Higgs P, Kerr T, Maher L

07 Jan 2022

"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success.

The International journal on drug policy

Schroeder SE, Drysdale K, Lafferty L, Baldry E, Marshall AD, Higgs P, Dietze P, Stoove M, Treloar C

27 Dec 2021

Barriers to women's disclosure of and treatment for substance use during pregnancy: A qualitative study.

Women and birth : journal of the Australian College of Midwives

Oni HT, Drake JA, Dietze P, Higgs P, Islam MM

10 Oct 2021

The association between depression and oral health related quality of life in people who inject drugs.

Drug and alcohol dependence

Abdelsalam S, Van Den Boom W, Higgs P, Dietze P, Erbas B

26 Mar 2021

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

The Lancet. Public health

Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L

06 Jan 2021

Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J

17 May 2021

The Melbourne Safe Injecting Room Attracted People Most in Need of Its Service.

American journal of preventive medicine

Van Den Boom W, Del Mar Quiroga M, Fetene DM, Agius PA, Higgs PG, Maher L, Hickman M, Stoové MA, Dietze PM

18 Feb 2021

The impact of Victoria's real time prescription monitoring system (SafeScript) in a cohort of people who inject drugs.

The Medical journal of Australia

Fetene DM, Higgs P, Nielsen S, Djordjevic F, Dietze P

27 Aug 2020

Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne, Australia.

Addiction (Abingdon, England)

Palmer A, Higgs P, Scott N, Agius P, Maher L, Dietze P

05 Feb 2020

Blood donation amongst people who inject drugs in Australia: research supporting policy change.

Vox sanguinis

Quinn B, Pearson R, Cutts J, Seed C, Scott N, Hoad V, Dietze P, Wilson D, Maher L, Thompson A

06 Nov 2019

Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.

Journal of public health (Oxford, England)

O'Keefe D, Scott N, Aitken C, Dietze P

30 Sep 2019

The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL

14 Dec 2018

Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.

PloS one

O'Keefe D, Wilkinson A, Aitken C, Dietze P

05 Dec 2018

Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs.

BMC health services research

Di Rico R, Nambiar D, Stoové M, Dietze P

28 Nov 2018

"I'm obviously not dying so it's not something I need to sort out today": Considering hepatitis C treatment in the era of direct acting antivirals.

Infection, disease & health

Wright C, Cogger S, Hsieh K, Goutzamanis S, Hellard M, Higgs P

29 Oct 2018

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

The Lancet. Infectious diseases

Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D

22 Aug 2018

Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.

Drug and alcohol dependence

O'Keefe D, Aitken C, Scott N, Dietze P

02 Aug 2018

Should sterile needle and syringe wastage be included within individual-level needle and syringe coverage measures?

The International journal on drug policy

Daniel O, Campbell A, Paul D

02 Apr 2018

Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.

BMC infectious diseases

Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P, TAP study group

16 Oct 2017

Are People Who Inject Drugs Frequent Users of Emergency Department Services? A Cohort Study (2008-2013).

Substance use & misuse

Nambiar D, Spelman T, Stoové M, Dietze P

29 Sep 2017

The Association between Intentional Overdose and Same-Sex Sexual Intercourse in a Cohort of People who Inject Drugs in Melbourne, Australia.

Substance use & misuse

O'Keefe D, Bowring A, Aitken C, Dietze P

18 Aug 2017

A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013.

BMJ open

Nambiar D, Stoové M, Hickman M, Dietze P

13 May 2017

Frequent emergency department presentations among people who inject drugs: A record linkage study.

The International journal on drug policy

Nambiar D, Stoové M, Dietze P

08 Dec 2016

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Epidemiology and infection

Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM

11 Sep 2016

Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia.

Drug and alcohol dependence

Scott N, Carrotte ER, Higgs P, Cogger S, Stoové MA, Aitken CK, Dietze PM

09 Dec 2015

Mortality in the Melbourne injecting drug user cohort study (MIX).

Harm reduction journal

Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P

23 Nov 2015

From initiating injecting drug use to regular injecting: Retrospective survival analysis of injecting progression within a sample of people who inject drugs regularly.

Drug and alcohol dependence

O'Keefe D, Horyniak D, Dietze P

17 Nov 2015

Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.

Substance use & misuse

Horyniak D, Agius PA, Degenhardt L, Reddel S, Higgs P, Aitken C, Stoové M, Dietze P

15 Jul 2015

Experiences of and attitudes toward injecting drug use among marginalized African migrant and refugee youth in Melbourne, Australia.

Journal of ethnicity in substance abuse

Horyniak D, Higgs P, Cogger S, Dietze P, Bofu T, Seid G

30 Jun 2015

Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.

Drug and alcohol dependence

Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P

23 Oct 2014

High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia.

Addiction (Abingdon, England)

Scott N, Caulkins JP, Ritter A, Quinn C, Dietze P

17 Sep 2014

How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.

The International journal on drug policy

Horyniak D, Stoové M, Degenhardt L, Aitken C, Kerr T, Dietze P

16 Jul 2014

A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs.

BMC health services research

Nambiar D, Stoové M, Dietze P

23 Jun 2014

Are users' most recent drug purchases representative?

Drug and alcohol dependence

Bond B, Caulkins JP, Scott N, Kilmer B, Dietze P

21 Jun 2013

Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results.

Harm reduction journal

Horyniak D, Higgs P, Jenkinson R, Degenhardt L, Stoové M, Kerr T, Hickman M, Aitken C, Dietze P

01 Nov 2012

A response to: Self-reported and actual hepatitis C virus infection status.

Drug and alcohol review

O'Keefe D, Aitken C, Higgs P, Dietze P

16 Sep 2012

The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing.

Drug and alcohol dependence

Dietze P, Jenkinson R, Aitken C, Stoové M, Jolley D, Hickman M, Kerr T

03 Sep 2012

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs.

Drug and alcohol review

O'Keefe D, Aitken C, Higgs P, Dietze P

16 Jul 2012

A cross-sectional study of emergency department visits by people who inject drugs.

Emergency medicine journal : EMJ

Aitken C, Kerr T, Hickman M, Stoové M, Higgs P, Dietze P

Partners

Funding partners

  • Colonial Foundation Trust

  • National Health and Medical Research Council (NHMRC). Grant IDs: 545891, 1126090, 2023690

Collaborators

  • Monash Rural Health 
  • British Columbia Centre on Substance Use  
  • Curtin University 
  • Deakin University 
  • University of Bristol 
  • School of Public Health and Preventive Medicine, Monash University 
  • Kirby Institute 
  • UNSW Sydney 
  • Alfred Health 
  • Harm Reduction Victoria 
  • Royal Melbourne Hospital 

Project contacts

Main contacts

Group mailbox

SuperMIX team

Student supervisor contacts

Dr Rachel Sacks-Davis

Dr Rachel Sacks-Davis

Senior Research Fellow
View profile
Professor Paul Dietze

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
View profile
Associate Professor Peter Higgs

Associate Professor Peter Higgs

Principal Research Fellow; Honorary Associate Professor, Department of Public Health, La Trobe University
View profile
Dr Michael Curtis

Dr Michael Curtis

Postdoctoral Research Officer
View profile
Dr Anna Wilkinson

Dr Anna Wilkinson

Research Fellow
View profile
Associate Professor Peter Higgs

Associate Professor Peter Higgs

Principal Research Fellow; Honorary Associate Professor, Department of Public Health, La Trobe University
View profile
Dr Rebecca Winter

Dr Rebecca Winter

Deputy Head Justice Health Group
View profile
Dr Shelley Walker

Dr Shelley Walker

Adjunct Research Fellow
View profile

Project team

Professor Paul Dietze

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
View profile
Shady Abdelsalam

Shady Abdelsalam

Master’s Student
View profile
Associate Professor Paul Agius

Associate Professor Paul Agius

Honorary Principal Research Fellow
View profile
Dr Campbell  Aitken

Dr Campbell Aitken

Research Fellow
View profile
Anja Busse

Anja Busse

Honorary Senior Fellow
View profile
Dr Jocelyn Chan

Dr Jocelyn Chan

Public Health Physician and Research Officer
View profile
Dr Samantha Colledge-Frisby

Dr Samantha Colledge-Frisby

Honorary Postdoctoral Research Fellow
View profile
Troy Combo

Troy Combo

Program Manager, Aboriginal Health Plan, EC Australia
View profile
Stephanie Curtis

Stephanie Curtis

Surveillance Officer / Master of Philosophy (Applied Epidemiology) Scholar
View profile
Dr Michael Curtis

Dr Michael Curtis

Postdoctoral Research Officer
View profile
Filip Djordjevic

Filip Djordjevic

Research Assistant
View profile
Professor Joseph (Joe) Doyle

Professor Joseph (Joe) Doyle

Deputy Program Director, Disease Elimination; Co-Head, Infectious Diseases Clinical Research; President, Hepatitis Australia; NHMRC Clinical Research Fellow
View profile
Dr Anna Hearps

Dr Anna Hearps

Deputy Program Director, Disease Elimination; Head, Infection, Inflammation and Innate Immunity Group
View profile
Associate Professor Peter Higgs

Associate Professor Peter Higgs

Principal Research Fellow; Honorary Associate Professor, Department of Public Health, La Trobe University
View profile
Zachary  Lloyd

Zachary Lloyd

Research Assistant
View profile
Rebekka (Bek) Petrovic

Rebekka (Bek) Petrovic

Research Assistant
View profile
Dr Amanda Roxburgh

Dr Amanda Roxburgh

Senior Research Fellow
View profile
Ashleigh Stewart

Ashleigh Stewart

Postdoctoral Research Fellow
View profile
Professor Mark A  Stoové

Professor Mark A Stoové

Head of Public Health
View profile
Dr Shelley Walker

Dr Shelley Walker

Adjunct Research Fellow
View profile
Bianca Whiteside

Bianca Whiteside

PhD candidate; Research Assistant
View profile
Joanna Wilson

Joanna Wilson

Research Assistant
View profile
Associate Professor Bernadette Ward

Associate Professor Bernadette Ward

Collaborator
Monash Rural Health
View profile
Dr Thomas Kerr

Dr Thomas Kerr

Collaborator
British Columbia Centre on Substance Use
View profile
Dr Jocelyn Jones

Dr Jocelyn Jones

Collaborator
Curtin University
View profile
Professor Matthew Hickman

Professor Matthew Hickman

Collaborator
University of Bristol
View profile
Associate Professor James Trauer

Associate Professor James Trauer

Head of Epidemiological Modelling
School of Public Health and Preventive Medicine, Monash University
View profile
Professor Lisa Maher

Professor Lisa Maher

Collaborator
Kirby Institute and UNSW Sydney
View profile
Associate Professor Andrew Stewardson

Associate Professor Andrew Stewardson

Infection Prevention and Healthcare Epidemiology
Alfred Health; Monash Univesity
View profile
Sione Crawford

Sione Crawford

Collaborator
Harm Reduction Australia
View profile
Associate Professor Nicholas  Clark

Associate Professor Nicholas Clark

Collaborator
Royal Melbourne Hospital
View profile
On this page